We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Applied Therapeutics Holds Off AT-007 Regulatory Push
Applied Therapeutics Holds Off AT-007 Regulatory Push
Applied Therapeutics got some coal in its stocking last week, when the FDA said the company needs clinical outcomes data, not just biomarker numbers, to support a New Drug Application (NDA) for AT-007, an investigational galactocemia treatment.